This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heartattack, and more, making it the focus of many heart health campaigns.
A recently unveiled cardiovasculardisease risk calculator that measures a patient's risk for heartattack and stroke is better calibrated and more precise than its previous version, but if current treatment guidelines for cholesterol and blood pressure therapy remain unchanged, the new calculator may have unintended consequences, according to research (..)
Researchers have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heartattack.
Researchers have discovered a better way of identifying those at high risk of potential heartattacks and strokes and other major cardiovasculardisease (CVD) events.
Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a single universal risk prediction model for cardiovasculardisease that, in initial tests, works well for patients who already have cardiovasculardisease as well as patients who do not but who may be at risk for developing it.
Researchers at Karolinska Institutet have identified a new potential risk marker for cardiovasculardisease in women. A new study shows an association between low levels of an anti-inflammatory antibody and the risk of heartattack and coronary heartdisease.
Researchers have identified a new potential risk marker for cardiovasculardisease in women. A new study shows an association between low levels of an anti-inflammatory antibody and the risk of heartattack and coronary heartdisease.
More than 70% of American Indian young adults aged 20-39 and 50% of American Indian teens have cholesterol levels or elevated fat in the blood that put them at risk for cardiovasculardisease, a new study suggests.
A review in The Lancet finds that 20% of the world population carries a genetic risk factor for cardiovasculardiseases such as heartattacks, strokes, and aortic valve stenosis: Increased levels of a lipid particle called lipoprotein(a). It is the most common genetic cause of cardiovasculardiseases.
Researchers have identified a new pathway that contributes to cardiovasculardisease associated with high levels of niacin, a common B vitamin previously recommended to lower cholesterol. The team discovered a link between 4PY, a breakdown product from excess niacin, and heartdisease.
However, for people with risks for heartdisease, these warning signals can have a negative consequence: they can increase the size of plaque in arteries, making them narrow, and trigger inflammatory events that can cause plaque to rupture. This can set the stage for a heartattack or stroke.
Over the past 15 years, researchers have identified hundreds of regions in the human genome associated with heartattack risk. However, researchers lack efficient ways to explore how these genetic variants are molecularly connected to cardiovasculardisease, limiting efforts to develop therapeutics.
(MedPage Today) -- Various hormonal contraceptives were linked to incident cardiovasculardisease in an analysis of Denmark's nationwide records. From a pool of over 2 million women of reproductive age, users of most methods of hormonal contraception.
When you look at the risk of having a heartattack, it is true that the older you are, the greater the odds of having a heartattack 1. While only 1-2% of those having a heartattack are less than 65 years of age, 1-2% of this very large number means a LOT of heartattacks. So far, so good.
Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. Coronary inflammation is a crucial piece of the puzzle in predicting heartattack risk.
The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardial infarction (STEMI), the most severe form of a heartattack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), 24), being held April 6-8 in Atltanta, GA.
Recent guidelines have restricted aspirin use in the primary prevention of cardiovasculardisease. The American Heart Association (AHA)/American College of Cardiology (ACC) guidelines restricted aspirin to patients under 70, and more recently, the United States Preventive Services Task Force restricted aspirin use to patients under 60.
A study based on clinical trial data found higher risks of stroke, heartattack, and hospital admission for heart failure in older cancer survivors. In the analysis published in the journal Cancer, chemotherapy was also linked to elevated rates of these conditions.
Smoking is a well-known health hazard, contributing to a wide array of diseases and conditions. Its effects on the heart are particularly alarming, as smoking significantly increases the risk of cardiovasculardiseases (CVDs) and complicates medical procedures such as minimally invasive or bloodless heart surgeries.
A projected rise in heartdisease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovasculardisease within the next 30 years, according to two new science reports. to 61% of the U.S. population.
Food and Drug Administration (FDA) for its PlaqueIQ imaging analysis software to help physicians diagnose cardiovasculardisease (CVD). Elucid has announced it received 510(k) clearance from the U.S.
Being heart healthy can prevent a heartattack or stroke by lowering your risk for heartdisease. To start you on the right path, there are several risk factors that doctors will tell you to focus on.
adults—and more than 2 in 5 adults aged 60 years and older—have elevated triglycerides, also known as hypertriglyceridemia , putting them at an increased risk for heartattacks and stroke. milla1cf Sun, 04/07/2024 - 18:20 April 7, 2024 — An estimated 1 in 5 U.S. and Canada. Patients’ median triglyceride level was 242 mg/dL.
When it comes to a proper ‘explanation’ of cardiovasculardisease or a ‘plan’ to address it, you will have to learn or address a lot of this on your own. Some doctors are less interested in cardiovasculardisease; their particular interest may be in another area, e.g., migraines or gastrointestinal health.
milla1cf Sun, 04/07/2024 - 18:09 April 7, 2024 — Among patients at high or very high risk for a heartattack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication for one year reduced LDL, or “bad” cholesterol, levels by more than half on average, compared with a placebo.
By varying the timing of heart beats for the upper and lower chambers, the new algorithm can lower blood pressure by several mechanisms and have a lasting benefit. Reducing high blood pressure lowers the risk of life-threatening strokes , heartattacks and cardiovasculardiseases.
Statement Highlights: The new American Heart Association PREVENTTM risk calculator estimates the 10- and 30-year risk of total cardiovasculardisease for people aged 30 years and older. The calculator estimates the risk of heartattack, stroke and —.
When it comes to cardiovasculardisease, two of the biggest risk factors we must consider are: ApoB concentration - A measure of the number of circulating lipid particles. The greater the number of particles the artery wall is exposed to over time, the higher the risk of atherosclerosis and a heartattack 2.
Objective Assessment of generalisability of guideline-informing trials on antithrombotic treatment intensification to real-world patients with cardiovasculardisease (CVD).
Aims:Asian Americans experience disproportionate burdens of cardiovascular risk factors and cardiovasculardisease (CVD). However, the trends in cardiovascular risks in adults from different Asian ethnic backgrounds remain understudied. Circulation, Volume 150, Issue Suppl_1 , Page A4140513-A4140513, November 12, 2024.
Here, we compare prevalence estimates and disparities in cardiometabolic diseases across 5 aggregated racial and ethnic groups.MethodsWe examined the age and fullyadjusted prevalence of cardiovasculardisease and diabetes among nonHispanic White, nonHispanic Black, Hispanic, nonHispanic Asian, and Other race respondents aged 30 years or older.
These patients often can’t control their blood pressure--placing them at significantly higher risk of heartattack, stroke and kidney failure.” The device delivers ultrasound energy through the arteries of the kidneys to deaden surrounding nerves that are overactive in many people with hypertension. Christine Albert, MD, MPH.
Exercise prevents and reverses cardiovasculardisease, but whether high-intensity exercise training (HIIT) is safe and effective for adults after minimally invasive heart surgery is unknown. Exercise is a wonder drug for cardiovasculardisease (CVD) prevention and reversal.
Obesity is also a key driver of risk for cardiovasculardisease. Poor Sleep Increases The Rate Of HeartAttacks & Stroke. Shortened sleep is now recognised as part of the eight key factors of good cardiovascular health. Poor Sleep Increases The Rate Of HeartAttacks & Stroke.
Less than two weeks after Novo Nordisk’s weight-loss drug Wegovy gained expanded FDA approval for cardiovascular event risk reduction, CMS issued a new Medicare Part D guidance that allows coverage of obesity drugs for senior patients with “an additional medically accepted indication”… like cardiovasculardisease.
This is precious time that could be spent managing their conditions to help them avoid having a heartattack or stroke at a young age. It found a high incidence of youth with risk factors for cardiovasculardisease but a significant lack of resources and personnel to provide the timely, preventive care they need.
High levels of triglycerides and the lipid particles on which they are carried in the blood can contribute to the formation of “plaques” in the arteries that impede blood flow and can lead to heartattacks and strokes. A total of 229 patients (average age 55 years, 78% men and 90% White) were enrolled in the trial in eight countries.
Maintaining cardiovascular health reduces the risk of developing various heartdiseases, including heartattack, stroke, and high blood pressure. Moreover, a healthy heart contributes to improved overall fitness, endurance, and quality of life.
Insufficient or interrupted sleep can affect blood pressure and increase the risk of heartattacks, stroke, diabetes, and other cardiovasculardiseases. High blood pressure and heartdisease are related to insomnia. They also have an increased risk of having a stroke or a heartattack.
What does it mean for your heart? Risk of CardiovascularDisease by COVID-19 Can COVID-19 damage the heart? Yes, COVID-19, primarily a respiratory disease, can affect the heart. Can COVID-19 symptoms mimic a heartattack? Risk posed by JN.1
The father of three and grandfather of eight, he has had three heartattacks in the last three years, which led to congestive heart failure. “I The therapy is designed to restore balance to the autonomic nervous system and thereby reduce the symptoms of heart failure.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content